Vikram Sadineni is senior research investigator, Department of Drug Product Science & Technology R&D, Bristol-Myers Squibb, New Brunswick, NJ 08903.
Implications of Trace Levels of Redox-Active Metals in Drug-Product Formulation
The presence of minute amounts of chelators can help minimize the degradation of monoclonal antibodies.